A treatment trial is proposed to test the efficacy of...

A treatment trial is proposed to test the efficacy of vitamin E as a preventive agent for cancer. One problem with such a study is how to assess compliance among participants. A small pilot study is undertaken to establish criteria for compliance with the proposed study agents. In this study, 10 patients are given 400 IU/day of vitamin $E$ and 10 patients are given similar-sized placebo capsules over a 3 -month period. Their serum vitamin E levels are measured before and after the 3 -month period, and the change (3-month - baseline) is shown in Table 5.2. Is the measure in Problem 5.38 a measure of sensitivity, specificity, or predictive value?

A treatment trial is proposed to test the efficacy of vitamin E as a preventive agent for cancer. One problem with such a study is how to assess compliance among participants. A small pilot study is undertaken to establish criteria for compliance with the proposed study agents. In this study, 10 patients are given 400 IU/day of vitamin $E$ and 10 patients are given similar-sized placebo capsules over a 3 -month period. Their serum vitamin E levels are measured before and after the 3 -month period, and the change (3-month - baseline) is shown in Table 5.2.
Is the measure in Problem 5.38 a measure of sensitivity, specificity, or predictive value?

Key Concepts

Pilot Study Design for Test Validation

A pilot study used to validate a test or measurement is a small-scale preliminary study conducted to determine the feasibility, time, cost, and effect size (or test performance characteristics) before undertaking a full-scale study. In the context of validating a compliance measurement tool, a pilot study can help establish appropriate cutoffs that differentiate between compliant and noncompliant behavior, and can provide estimates of the test’s sensitivity, specificity, and predictive value.

Compliance Assessment

Compliance assessment in clinical trials involves verifying that participants are following the prescribed treatment regimen. This may be done through self-reports, pill counts, or biological markers that reflect the ingestion of the therapeutic agent. Establishing a reliable method for measuring compliance is critical, as noncompliance can confound the results of a trial and lead to incorrect conclusions about the efficacy of an intervention.

Sensitivity

Sensitivity is the ability of a test to correctly identify those individuals who have the condition or characteristic of interest. In the context of evaluating a measurement used for compliance, sensitivity would refer to the proportion of truly compliant participants (those who truly took the agent) who are correctly identified as such by the test. It is an important characteristic when the primary concern is not to miss cases that are truly positive.

Specificity

Specificity is the ability of a test to correctly identify those individuals who do not have the condition or characteristic of interest. In diagnostic testing, high specificity means that most individuals who are noncompliant (or who do not have the condition) are correctly labeled negative by the test. This property helps reduce the number of false-positive results.

Predictive Value

Predictive value, including positive and negative predictive values, refers to the likelihood that a test result truly reflects the condition in question. In the context of compliance assessment, the predictive value indicates how well a test result (for example, a change in a biological marker) predicts whether a participant is actually taking the prescribed agent. This measure incorporates both the performance of the test and the prevalence of the condition (i.e., compliance) in the study population, making it very relevant for determining how useful the test will be in practice.

Transcript

00:01 In this exercise, we are given the scenario where 20 % of british children are considered deficient in vitamin d, and doctors are going to test a group of elementary school children.

00:14 So to begin, let's assume that these are bernoulli trials.

00:18 So for each trial, the child either has a vitamin d deficiency or not, so there's a kind of a success, failure type of outcome.

00:25 The probability of success is the same on each trial, which is 20%.

00:30 So we're defining success as a child being deficient in vitamin d.

00:36 And that each trial is independent from the others.

00:40 So the test for one child is independent for the test for any other child.

00:46 So with that in mind, in part a we are asked, what is the probability that the first vitamin d deficient child is the eighth one tested? so let's define x as the number of tests to find the first vitamin d deficient child.

01:22 So in this case, x is a geometric random variable with probability of success of 0 .2.

01:32 Recall that for a geometric random variable, the probability of the first success occurring on the kth trial is equal to the following.

01:50 So if we're looking for the probability of getting our first success on the eighth trial, this is the probability that the first vitamin d deficient child is the eighth one tested.

02:04 Equal to 0 .8 to the exponent 7 times 0 .2.

02:10 And this comes out to about 0 .042.

02:18 For part b, we are as the probability that all of the first 10 children tested are okay.

02:27 So here let's define x as the number of vitamin d deficient children in 10.

02:42 So the probability that all of the children, all 10 children are okay is the same as the probability that we have zero who are vitamin d deficient.

02:53 Now remember that the probability mass function for a binomial random variable, and this is, we're looking at the number of successes in 10 trials.

03:04 So x is a binomial based on 10 trials and probability of success of 0 .2.

03:12 We're considering a child to be deficient in vitamin d as a child.

03:16 Success.

03:18 So the probability mass function for getting k successes is n choose k times p to the exponent k times q to the exponent n minus k.

03:33 So here this simplifies to 0 .8 to the exponent 10, which is 0 .107.

03:43 So there's about a 10 .7 % chance that out of 10 children tested, none of them will be deficient in vitamin d.

04:00 We want to know how many kids are expected to be tested before finding one who has the vitamin d deficiency.

04:08 So now we are back to this definition of a random variable.

04:14 The number of tests to find the first vitamin d deficient child...